Examples of using Multocida in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Pasteurella multocida is a gram-negative bacillus.
Treatment of respiratory infections due to Pasteurella multocida.
Pasteurella multocida related encephalitis or otitis interna.
Treatment of respiratory infections due to Pasteurella multocida and Mannheimia haemolytica.
Of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.
With tilmicosin-susceptible microorganisms such as Mycoplasma spp. Pasteurella multocida, Actinobacillus.
Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica and Haemophilus parasuis, which are the bacterial pathogens most commonly associated with swine respiratory disease SRD.
Protein dO non-toxic deletion derivative of Pasteurella multocida.
In vitro, the effect of tildipirosin is bacteriostatic against Pasteurella multocida and B. bronchiseptica, and bactericidal for A. pleuropneumoniae and H. parasuis.
Tylosin Injection is indicated for use in the treatment of bovine respiratory complex(shipping fever, pneumonia)usually associated with Pasteurella multocida and Actinomyces pyogenes;
The Pasteurella multocida toxin is made by a bacterium cell that has received a gene(DNA), which makes it able to produce Pasteurella multocida toxoid, a genetically modified form of toxin which has adequate immunogenic activity and which is free from the toxic properties.
Protein dO(non-toxic deletion derivative of Pasteurella multocida) dermonecrotic toxin.
Tulathromycin possesses in vitro activity against Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis, and Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoni, and Haemophilus parasuis the bacterial pathogens most commonly associated with bovine and swine respiratory disease.
For the second clinical study“ Efficacy of the doxycycline infeed for the control of pneumonia caused by P. multocida and Mycoplasma hyopneumoniae.
Following discussions in the CMD(v), the proposed indication was changed during the course of the MRP to:“ For treatment of swinerespiratory disease caused by susceptible Pasteurella multocida, Bordetella bronchiseptica and Mycoplasma hyopneumoniae to doxycycline.” Germany notified the EMEA on 30 May 2006 that the CMD(v) failed to reach an agreement regarding the product.
F lorfen ic ol injection is indicated for preventive and therapeutic treatment of respiratory tract infections in cattle due to Mannheimia haemolytica,Pasteurella multocida and Histophilus somni.
Laboratory tests have shown that florfenicol is active against the most commonly isolated bacterial pathogens involved in bovine respiratory disease which include Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Arcanobacterium pyogenes, and against the bacterial pathogens most commonly isolated in respiratory diseases in pigs, including Actinobacillus pleuropneumoniae and Pasteurella multocida.
Florfenicol Injection is indicated for preventive and therapeutic treatment of respiratory tract infections in cattle due to Mannheimia haemolytica,Pasteurella multocida and Histophilus somni.
Treatment of: acute infections of the upper respiratorytract caused by susceptible strains of Pasteurella multocida, Escherichia coli and the Staphylococcus intermedius group including.
Dicural 50 mg/ ml solution for injection is indicated for the treatment of bovine respiratory disease(shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica,Pasteurella multocida, and/ or Mycoplasma spp.
The Committee for Medicinal Products for Veterinary Use(CVMP) concluded that the benefits of Zactran exceeded the risks for the therapeutic and preventive treatment of bovine respiratory disease(BRD) associated with Mannheimia haemolytica,Pasteurella multocida and Histophilus somni,(the presence of the disease in the herd should be established before preventive treatment) and recommended that Zactran should be given a marketing authorisation.
From all this information, a significant potential serious risk for safety or efficacy of Doxyprex, for the treatment or control of clinical signs ofporcine respiratory disease caused by P. multocida and B. bronchiseptica cannot be identified.
Porcilis AR-T DF contains a non-toxic recombinant derivative(see‘ How does Porcilis AR-T DF work?')of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.
For passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated withBordetella bronchiseptica and Pasteurella multocida infections during the fattening period.
Treatment and metaphylaxis of bovine respiratory disease(BRD) associated with Mannheimia haemolytica,Pasteurella multocida, Histophilus somni and Mycoplasma bovis sensitive to tulathromycin.
It is used to reduce the clinical signs and lesions of a disease called progressive and non-progressive atrophic rhinitis, as wellas to reduce weight loss associated with Bordetella bronchiseptica and Pasteurella multocida infections during the fattening period.
In Spain the product has been authorised for the indication the treatment ofswine respiratory disease caused by Pasteurella multocida, Bordetella bronchiseptica and Mycoplasma hyopneumoniae.
Terramycin Powder 20% is effective against Actinomyces, Rickettsia, Mycoplasma and Chlamydia and is thereforere commended for treatment of Mortellaro, Moraxella bovis conjunctivitis in calves, Atrophic Rhinitis and MMA syndrome in pigs,Pasteurella multocida and Mycoplasma infections in poultry.
Zuprevo is an antibiotic used in pigs to treat swine respiratory disease(SRD) associated with Actinobacillus pleuropneumoniae,Pasteurella multocida, Bordetella bronchiseptica and Haemophilus parasuis.
Porcilis AR-T DF is a suspension for injection which contains a non-toxic recombinant derivative(see‘How does Porcilis AR-T DF work?')of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.